GEA
RGEN icon

Glen Eagle Advisors’s Repligen RGEN Stock Holding History

Glen Eagle Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Hold
8,287
– – 0.14% 106
2026
Q1 		$976K Hold
8,287
– – 0.14% 114
2025
Q4 		$1.36M Sell
8,287
-2,184
-21% -$342K 0.18% 88
2025
Q3 		$1.4M Sell
10,471
-10,472
-50% -$1.27M 0.19% 88
2025
Q2 		$2.6M Buy
+20,943
New +$2.67M 0.4% 45

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Glen Eagle Advisors's RGEN Position: Q2 2026 in Review

Glen Eagle Advisors held its Repligen (RGEN) position steady in Q2 2026 at 8,287 shares worth $1.13M. The position accounts for 0.14% of the portfolio, ranked #106.

Glen Eagle Advisors first reported a position in RGEN in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.6M in Q2 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Glen Eagle Advisors held 8,287 shares of Repligen worth $1.13M as of Q2 2026.
  • Glen Eagle Advisors left its Repligen share count unchanged in Q2 2026.
  • Repligen made up 0.14% of Glen Eagle Advisors's portfolio in Q2 2026, its #106 holding.
  • Glen Eagle Advisors first reported a position in Repligen in Q2 2025 and has held it in 5 quarters since.
  • Glen Eagle Advisors's Repligen position peaked at $2.6M in Q2 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.